Skip to main content
Equibles

OpenArc Corporate Advisory, LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 2111345 ATLANTA, GA
Back to TVTX Full portfolio

Position in TVTX

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$2,130,375
+$1,209,365 QoQ
Shares Held
37,500
+21.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#139
of 318 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OpenArc Corporate Advisory, LLC holds $10,123,972 across 17 Biotechnology names. TVTX ranks #1 (21.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TVTX
Travere Therapeutics, Inc.
This page 		37,500 $2,130,375
2 HALO
Halozyme Therapeutics, Inc.
 20,310 $1,589,663
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,397 $1,190,661
4 ARQT
Arcutis Biotherapeutics, Inc.
 30,700 $804,954
5 PBYI
Puma Biotechnology, Inc.
 59,491 $482,472
6 PHVS
Pharvaris N.V.
 13,595 $470,115
7 ARGX
Argenx SE
 500 $463,885
8 REGN
Regeneron Pharmaceuticals, Inc.
 688 $428,995

All Filings in TVTX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,130,375 37,500
2026-03-31 $921,010 31,000
2025-12-31 $1,184,510 31,000